Long-term disease control of ≥2 years achieved with cabozantinib in subjects with metastatic medullary thyroid carcinoma on a phase I study Meeting Abstract


Authors: Cohen, E. E. W.; Hong, D. S.; Pfister, D. G.; Salgia, R.; Burtness, B.; Cohen, R. B.; Ball, D. W.; Mehra, R.; Mangeshkar, M.; Yaron, Y.; Bentzien, F.; Kurzrock, R.
Abstract Title: Long-term disease control of ≥2 years achieved with cabozantinib in subjects with metastatic medullary thyroid carcinoma on a phase I study
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419602213
PROVIDER: wos
DOI: 10.1200/jco.2013.31.15_suppl.6090
Notes: Meeting Abstract: 6090 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David G Pfister
    389 Pfister